Drawing for MATERIALIZING SOLUTIONS

USPTO serial 90501795

MATERIALIZING SOLUTIONS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JAGANNATHAN, SIDDHARTH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MATERIALIZING SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William E. Anderson

William E. Anderson CHRISTENSEN, FONDER, DARDI & HERBERT PLLC11322 86TH AVENUE NORTHMAPLE GROVE, MN 55369United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations in the nature of implantable materials, namely, pliable, synthetic hydrogel for medical and surgical purposes; pharmaceutical preparations in the nature of implantable materials, namely, pliable, synthetic hydrogel for embolization therapy in interventional radiology and oncology; pharmaceutical preparations, namely, differentiated liquid embolics for interventional radiology; embolic agents delivered through a microcatheter under fluoroscopic control; kits that contain precursors that react to form a hydrogel when combined with each other and applicators therefore for use in medical and surgical procedures; system for vascular embolization procedures, namely, a embolization therapy system, featuring hydrogel precursors and applicator; a kit for vascular embolization procedures, featuring hydrogel precursors and applicatorACTIVE—
010Surgical apparatuses and instruments; embolic device for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; embolic devices in the nature of liquid embolics delivered through microcatheter systems for interventional radiology, namely, interventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, organs and segmental embolizations; in situ polymerizing hydrogel-based medical devices for the treatment of anomalies in the vasculature of the bodyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 8, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 8, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 1, 2024EX5GSOU EXTENSION 5 GRANTED—
Aug 1, 2024EXT5SOU EXTENSION 5 FILED—
Aug 1, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 3, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 1, 2024EX4GSOU EXTENSION 4 GRANTED—
Feb 1, 2024EXT4SOU EXTENSION 4 FILED—
Feb 1, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 3, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 1, 2023EX3GSOU EXTENSION 3 GRANTED—
Aug 1, 2023EXT3SOU EXTENSION 3 FILED—
Aug 1, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 1, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 30, 2023EX2GSOU EXTENSION 2 GRANTED—
Jan 30, 2023EXT2SOU EXTENSION 2 FILED—
Jan 30, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 1, 2022EX1GSOU EXTENSION 1 GRANTED—
Aug 1, 2022EXT1SOU EXTENSION 1 FILED—
Aug 1, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 1, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 3, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 3, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 2, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 2, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2021DOCKASSIGNED TO EXAMINER—
May 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 4, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance